|
gptkbp:instance_of
|
gptkb:beer
|
|
gptkbp:bfsLayer
|
4
|
|
gptkbp:bfsParent
|
gptkb:Willie's_Reserve_CBD
|
|
gptkbp:developed_by
|
hemp
Cannabis sativa
marijuana
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
cannabidiol
|
|
gptkbp:is_available_on
|
prescription medication
over-the-counter product
|
|
gptkbp:is_known_for
|
antioxidant properties
anti-inflammatory properties
therapeutic properties
neuroprotective properties
anti-anxiety effects
|
|
gptkbp:is_part_of
|
gptkb:full-spectrum_CBD
gptkb:medical_cannabis
CBD oil
CBD isolate
broad-spectrum CBD
|
|
gptkbp:is_promoted_by
|
gptkb:hospital
wellness brands
|
|
gptkbp:is_studied_in
|
pain relief
anxiety reduction
sleep improvement
anti-inflammatory effects
anti-seizure effects
|
|
gptkbp:is_used_by
|
health enthusiasts
patients
|
|
gptkbp:is_used_for
|
gptkb:psychologist
anxiety
chronic pain
inflammation
|
|
gptkbp:is_used_in
|
gptkb:product
topicals
oils
|
|
gptkbp:legal_issue
|
gptkb:legislation
gptkb:Australia
gptkb:New_Zealand
gptkb:United_States
gptkb:Native_American_tribe
varies by country
|
|
gptkbp:marketed_as
|
gptkb:product
gptkb:drug
wellness product
|
|
gptkbp:non_comedogenic
|
gptkb:theorem
|
|
gptkbp:regulates
|
gptkb:FDA
gptkb:Health_Canada
gptkb:European_Medicines_Agency
|
|
gptkbp:research
|
gptkb:healthcare_organization
gptkb:psychologist
schizophrenia
|
|
gptkbp:side_effect
|
fatigue
diarrhea
dry mouth
changes in appetite
|